Cargando…
Downregulation of ubiquitin-specific protease 2 possesses prognostic and diagnostic value and promotes the clear cell renal cell carcinoma progression
BACKGROUND: Clear cell renal cell carcinoma (ccRCC), characterized by high mortality, invasion, metastasis, recurrence and drug resistance, is the most common malignant tumor of the urinary system. A clear understanding of the underlying molecular mechanisms and its role during tumorigenesis of RCC...
Autores principales: | Meng, Xiangui, Xiong, Zhiyong, Xiao, Wen, Yuan, Changfei, Wang, Cheng, Huang, Yu, Tong, Junwei, Shi, Jian, Chen, Zhixian, Liu, Chenchen, Xie, Kairu, Xiong, Hailong, Chen, Ke, Yang, Hongmei, Zhang, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186618/ https://www.ncbi.nlm.nih.gov/pubmed/32355763 http://dx.doi.org/10.21037/atm.2020.02.141 |
Ejemplares similares
-
HIF2α promotes tumour growth in clear cell renal cell carcinoma by increasing the expression of NUDT1 to reduce oxidative stress
por: Shi, Jian, et al.
Publicado: (2021) -
Impact of inflammation and immunotherapy in renal cell carcinoma
por: Shi, Jian, et al.
Publicado: (2020) -
Overexpression of PPT2 Represses the Clear Cell Renal Cell Carcinoma Progression by Reducing Epithelial-to-mesenchymal Transition
por: Yuan, ChangFei, et al.
Publicado: (2020) -
Downregulation of miR-29c promotes muscle wasting by modulating the activity of leukemia inhibitory factor in lung cancer cachexia
por: Xie, Kairu, et al.
Publicado: (2021) -
As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner
por: Miao, Daojia, et al.
Publicado: (2022)